Home > Products > CA19-9 & CD3
> Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-026)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (CrossMab) (CROSSAB-026). Click the button below to contact us or submit your feedback about this product.